<SEC-DOCUMENT>0001144204-18-033070.txt : 20180606
<SEC-HEADER>0001144204-18-033070.hdr.sgml : 20180606
<ACCEPTANCE-DATETIME>20180606164838
ACCESSION NUMBER:		0001144204-18-033070
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180531
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180606
DATE AS OF CHANGE:		20180606

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		18884352

	BUSINESS ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-839-5200

	MAIL ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv495966_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 409.5pt"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 409.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM
8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PURSUANT
TO SECTION 13 OR 15(d) OF <BR>
THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date
of earliest event reported): May 31, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 14pt"><B>APOLLO
MEDICAL HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 34%; text-align: center"><FONT STYLE="font-size: 10pt">001-37392</FONT></TD>
    <TD STYLE="width: 33%; text-align: center"><FONT STYLE="font-size: 10pt">46-3837784 </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Number)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Identification Number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">1668 S. Garfield Avenue,
2nd Floor, Alhambra, CA 91801</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive
offices) (zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(626) 282-0288</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&rsquo;s telephone
number, including area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">N/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former
address, if changed since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Precommencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Precommencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &sect;240.12b-2). Emerging growth company&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14pt"></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 5.02</B></FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Departure of Directors or Certain Officers;
        Election of Directors; Appointment of Certain Officers; Compensatory</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Arrangements of Certain Officers.</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Termination
of Employment Agreements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On May 31, 2018,
Apollo Medical Management, Inc. (&ldquo;AMM&rdquo;) a wholly-owned subsidiary of Apollo Medical Holdings, Inc. (the &ldquo;Company&rdquo;),
provided to Gary Augusta, the President of the Company, notice of termination (the &ldquo;Augusta Notice of Termination&rdquo;)
of that certain Employment Agreement, dated December 20, 2016 (the &ldquo;Augusta Employment Agreement&rdquo;), between AMM and
Mr. Augusta. Pursuant to the Augusta Notice of Termination, and in accordance with the Augusta Employment Agreement, the effective
date of termination of the Augusta Employment Agreement is thirty (30) days after the date on which the Augusta Notice of Termination
is given to Mr. Augusta (the &ldquo;Augusta Termination Date&rdquo;). Mr. Augusta will continue in his current role with the Company
until the Augusta Termination Date and, thereafter, will continue to serve as a director on the Company&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On May 31, 2018,
AMM provided to Mihir Shah, the Chief Financial Officer of the Company, notice of termination (the &ldquo;Shah Notice of Termination&rdquo;)
of that certain Employment Agreement, dated December 20, 2016 (as amended effective July 1, 2017, the &ldquo;Shah Employment Agreement&rdquo;),
between AMM and Mr. Shah. Pursuant to the Shah Notice of Termination, and in accordance with the Shah Employment Agreement, the
effective date of termination of the Shah Employment Agreement is thirty (30) days after the date on which the Shah Notice of Termination
is given to Mr. Shah (the &ldquo;Shah Termination Date&rdquo;). Mr. Shah will continue in his current role with the Company until
the Shah Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Appointment of new Chief Financial
Officer</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 5, 2018, Eric Chin entered into an employment agreement
with the Company pursuant to which Mr. Chin will serve as the new Chief Financial Officer of the Company, effective upon the Shah
Termination Date. Mr. Chin, the current Chief Financial Officer of Network Medical Management, Inc. (&ldquo;NMM&rdquo;), the Company&rsquo;s
wholly-owned subsidiary, will continue to serve as the Chief Financial Officer of NMM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Chin, 38, joined NMM as its Chief Financial Officer in March
2018. From October 2015 to March 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage, Inc.,
a New York Stock Exchange listed company and a member of the S&amp;P 500. From May 2011 to October 2015, he served as Assistant
Vice-President - Financial Reporting of Alexandria Real Estate Equities, Inc., a New York Stock Exchange listed company and a member
of the S&amp;P 500. Mr. Chin began his career at Ernst &amp; Young LLP. In his role as an Assurance Senior Manager at Ernst &amp;
Young LLP, from October 2002 to May 2011, Mr.&nbsp;Chin provided assurance services to both publicly traded companies and private
companies. Mr. Chin is a certified public accountant. Mr. Chin received his Bachelor of Arts degree in Business/Economics with
Accounting and Computing from the University of California, Los Angeles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the employment agreement between the Company and Mr. Chin,
the Company agreed to (i) pay Mr. Chin an annual salary of $300,000, (ii) pay Mr. Chin a $30,000 guaranteed minimum bonus annually
(prorated if he is terminated without cause), and (iii) grant Mr. Chin, on an annual basis, options to acquire such number of shares
of common stock of the Company having an aggregate valuation in the amount of $30,000 based on the then-current fair market value
of such common stock. Mr. Chin&rsquo;s employment with the Company is &ldquo;at-will&rdquo; and will not be for any specific period
of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It is expected that Mr. Chin will enter into the Company&rsquo;s
standard form of indemnity agreement, the form of which was filed as an exhibit to the Company&rsquo;s Form 8-K filed on December
13, 2017 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no arrangements or understandings between Mr. Chin
and any other persons pursuant to which he was chosen as an officer of the Company. There are no family relationships between Mr.
Chin and any of the Company&rsquo;s directors, executive officers, or persons nominated or chosen by the Company to become a director
or executive officer. Mr. Chin is not a party to any current or proposed transaction with the Company for which disclosure is required
under Item 404(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 8.01</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Other Events</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On June 6, 2018, the Company issued a press
release announcing the appointment of its new Chief Financial Officer. A copy of the press release is attached hereto as Exhibit
99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Item 9.01</B></FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Financial Statements And Exhibits</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 13%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 85%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><A HREF="tv495966_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><A HREF="tv495966_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Press Release of Apollo Medical Holdings, Inc., dated June 6, 2018.</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.15pt 0pt 14pt; text-align: justify; text-indent: 36.05pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 294.9pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: June 6, 2018</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Thomas S. Lam</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Thomas S. Lam, M.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Co-Chief Executive Officer</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv495966_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS ANNOUNCES APPOINTMENT
OF NEW CHIEF FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><I>Alhambra,
CA and Glendale, CA &ndash; (PR Newswire) &ndash; June 6, 2018 &ndash; </I></B></FONT><B>Apollo Medical Holdings, Inc.</B> (&ldquo;ApolloMed&rdquo;
or &ldquo;the Company&rdquo;) (NASDAQ: AMEH), an integrated population health management company, is pleased to announce the appointment
of Eric Chin as the Company&rsquo;s new Chief Financial Officer effective July 1, 2018. Mr. Chin will be replacing Mihir Shah,
who has served as ApolloMed&rsquo;s CFO for the past two years. Additionally, the Company has decided to eliminate the position
of President, currently held by Gary Augusta, and transfer those duties to ApolloMed&rsquo;s Co-CEOs, Warren Hosseinion, M.D.
and Thomas Lam, M.D. Mr. Augusta will remain as a member of ApolloMed&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As CFO, Mr. Chin will be responsible for
overseeing all financial aspects of the Company, including financial planning and analysis, accounting and financial reporting,
as well as managing the internal audit, tax and treasury functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Chin has served as the Chief Financial
Officer of Network Medical Management, Inc., one of the Company&rsquo;s subsidiaries, since March 2018. Prior to joining Network
Medical, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage, Inc., a New York Stock Exchange listed
company and a member of the S&amp;P 500. From May 2011 to October 2015, he served as Assistant Vice-President - Financial Reporting
of Alexandria Real Estate Equities, Inc., a New York Stock Exchange listed company and a member of the S&amp;P 500. Mr. Chin began
his career at Ernst &amp; Young LLP in 2002. In his role as an Assurance Senior Manager at Ernst &amp; Young LLP, Mr. Chin provided
assurance services to both publicly traded companies and private companies. In addition to providing audit and attestation services,
Mr. Chin assisted clients with services related to equity offerings, debt offerings and technical research.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Chin is a Certified Public Accountant.
He received his Bachelor of Arts degree in Business/Economics with Accounting and Computing from UCLA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We are excited to have Eric join
our team,&rdquo; stated Warren Hosseinion, M.D., Co-Chief Executive Officer of Apollo Medical Holdings. &ldquo;He brings excellent
credentials in both the public and private capital markets, a proven track record of financial stewardship and strong operational
skills.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;On behalf of our Board, our executive
team and our employees, we wish Mihir and Gary the best in their future endeavors,&rdquo; added Warren Hosseinion, M.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We welcome Eric to the executive
management team,&rdquo; stated Kenneth Sim, M.D., Executive Chairman of Apollo Medical Holdings. &ldquo;He will be an asset to
the Company as we continue to execute on our growth initiatives.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;ApolloMed is a leader in the population
health management industry that leverages its core strengths of clinical expertise, its proven ability to profitably assume capitated
financial risk for its patients and its technology platform,&rdquo; stated Eric Chin. &ldquo;I am excited to join ApolloMed&rsquo;s
passionate executive team.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Apollo Medical Holdings, Inc.
(ApolloMed)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; background-color: white"><FONT STYLE="background-color: white">ApolloMed
is a leading physician-centric integrated population health management company, which, together with its subsidiaries, including
a Next Generation Accountable Care Organization (&ldquo;NGACO&rdquo;), and its affiliated Independent Physician Associations (each,
an &ldquo;IPA&rdquo;), are working to provide coordinated, outcomes-based high-quality medical care for patients, particularly
senior patients and patients with multiple chronic conditions, in a cost-effective manner.&nbsp; Led by a management team with
over two decades of experience,&nbsp; ApolloMed is addressing the healthcare needs of its patients by leveraging its integrated
health management and healthcare delivery platform that includes: Network Medical Management (MSO), &nbsp;Apollo Medical Management
(MSO), ApolloMed Hospitalists,&nbsp;APA ACO&nbsp;(Next Generation ACO), Allied Physicians of&nbsp;California&nbsp;(IPA), Maverick
Medical Group (IPA) and Apollo Care Connect (Digital Population Health Management Platform). ApolloMed strives to improve medical
outcomes with high-quality, cost-efficient care.&nbsp; For more information, please visit&nbsp;www.apollomed.net.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; color: #333333"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><I>This
press release contains forward-looking statements&nbsp;within the meaning of the Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such
as statements about the potential contributions of the Company&rsquo;s newly appointed executive officer and the Company&rsquo;s
ability to leverage its core strengths.&nbsp;Forward-looking statements reflect current views with respect to future events and
financial performance and therefore cannot be guaranteed.&nbsp;Such statements are based&nbsp;on&nbsp;the current expectations
and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize
or may vary significantly from actual results.&nbsp;Actual results may also vary materially from forward-looking statements due
to risks, uncertainties and other factors, known and unknown, including the risk </I></FONT><I><FONT STYLE="background-color: white">factors
described from time to time in the Company's reports to the U.S. Securities&nbsp;and Exchange Commission (including without limitation
the&nbsp;&rdquo;Risk Factors&rdquo; discussed in the&nbsp;Company's</FONT></I>&nbsp;<I>Annual Report on Form 10-K filed on&nbsp;April
2, 2018).</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>For
More Information, PLEASE CONTACT:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><B>Warren Hosseinion, M.D.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Co-Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">Apollo Medical Holdings</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">(818) 839-5200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt">warrenhoss@apollomed.net<B>&#9; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !U 5(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQDTQ]-9%="K %2,$&G45PG8>=ZOI0L=1DC4?NS\R?2J/V;VKLO$4*RR0N.2
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MX0C/XUP/P;_Y'27_ *]C_.@#G_'G_([:K_UUKUO3_P#DBA_Z\G_F:\D\>?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
